Records containing: Migraine Disorders
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-16Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
-
CLINICAL_TRIALS study record update · 2017-02-24Randomized Double-Blind Study to Evaluate the Dose-Related Efficacy and Safety of Caffeine/Propranolol in the Treatment of Acute Migraine
-
CLINICAL_TRIALS study record update · 2017-01-23A Randomized, Double-blind, Single Migraine Attack, Placebo-controlled, Parallel-group Multicenter Study to Evaluate the Efficacy and Tolerability of Trexima (Sumatriptan Succinate.Naproxen Sodium) Tablets vs Placebo When Administered During the Mild Pain Phase of Menstrual Migraine in Women With Dysmenorrhea
-
CLINICAL_TRIALS study record update · 2017-01-06ClinicalTrials.gov study NCT01516892
-
CLINICAL_TRIALS study record update · 2017-01-04Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-12-29The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine
-
CLINICAL_TRIALS study record update · 2016-12-12ClinicalTrials.gov study NCT01432379
-
CLINICAL_TRIALS study record update · 2016-10-26A Randomized, Double-blind, Multi-center, Placebo-controlled, Cross-over Study to Determine the Consistency of Response for Trexima* (Sumatriptan 85mg/Naproxen Sodium 500mg) Administered During the Mild Pain Phase for the Acute Treatment of Multiple Migraine Attacks (*Treximet)
-
CLINICAL_TRIALS study record update · 2016-10-24A Randomized, Double-blind, Single Migraine Attack, Placebo -Controlled, Patallel-group Multicenter Study to Evaluate the Efficacy and Tolerability or Trexima (Sumatriptan Succinate/Naproxen Sodium) Tablets vs Placebo When Administered During the Mild Pain Phase of Menstrual Migraine in Women With Dysmenorrhea
-
CLINICAL_TRIALS study record update · 2016-09-30MedlinePlus Health Prescriptions: Developing a Real World Approach for Clinic Use
-
CLINICAL_TRIALS study record update · 2016-06-29Transcranial Direct Current Simulation Over Primary Motor vs Prefrontal Cortex in Chronic Migraine: a Pilot Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2016-05-27ClinicalTrials.gov study NCT02147561
-
CLINICAL_TRIALS study record update · 2016-05-23Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Migraine. Safety Issues.
-
CLINICAL_TRIALS study record update · 2016-05-11Effect of Transcranial Direct Current Stimulation (tDCS) Optimized Protocol for the Treatment of Migraine
-
CLINICAL_TRIALS study record update · 2016-05-11Optimizing the Effect of Transcranial Direct Current Stimulation (tDCS) for the Treatment of Migraine
-
CLINICAL_TRIALS study record update · 2016-05-09A Multicentre, Two-part, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Tolerability and Pharmacokinetics of the iNOS Inhibitor GW274150 Administered up to 120mg Daily for 12 Weeks in the Prophylactic Treatment of Migraine.
-
CLINICAL_TRIALS study record update · 2016-03-31Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine.
-
CLINICAL_TRIALS study record update · 2016-03-15ClinicalTrials.gov study NCT01946126
-
CLINICAL_TRIALS study record update · 2016-02-03A Phase I, Open Label, Single-Dose, Four-Way Crossover Study Comparing the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) With an Oral Formulation of Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
-
CLINICAL_TRIALS study record update · 2016-02-03A Phase I, Single Center, Open Label, Single-Dose, Five-Period Study to Compare the Pharmacokinetics of NP101 (Sumatriptan Iontophoretic Transdermal Patch) in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2016-01-27Chemical Composition and Therapeutic Effects of Lippia Alba (Mill.) N. E. Brown Leaves Ethanolic Extract in Patients With Migraine
-
CLINICAL_TRIALS study record update · 2015-08-13Special Drug Use Investigation for AMERGE Tablet (Long-term)
-
CLINICAL_TRIALS study record update · 2015-04-23Effect of Topiramate on Cerebrovascular Response to Photic Stimulation in Migraineurs
-
CLINICAL_TRIALS study record update · 2015-04-16A Randomized, Double-blind, Multi-center, Placebo-controlled, Cross-over Study to Determine the Consistency of Response for Trexima (Sumatriptan 85mg/Naproxen Sodium 500mg) Administered During the Mild Pain Phase for the Acute Treatment of Multiple Migraine Attacks
-
CLINICAL_TRIALS study record update · 2015-04-08ClinicalTrials.gov study NCT01976611